Delta 8 Expo Florida

October 6 – 7, 2022 | Orlando, FL

MACE Media Group, pioneers of education in the CBD and Psychedelic industries, heads to Orlando, Florida for its 30th tradeshow event, and fifth time in Orlando, FL. The Delta 8 Expo in Partnership with the CBD Expo Tour will be a two-day event showcasing the latest innovative products out in the CBD and Cannabinoid markets. As well as, offer top-tier education on the latest research and trends in the CBD, Extraction, and Psychedelic space.

The expo will be held on October 6th – 7th, 2022 at the Hilton Orlando in Orlando, Florida, and will feature over 60 exhibitors, live demos on extraction testing equipment, and culinary demos. Across the hall in two separate rooms, hourly panel discussions and talks will be held on subject matters curated for impact and importance.

This expo will be the first to introduce MACE Media Groups’ talks series. The Doc Talks, which will be held on October 7th, will allow Medical Doctors of all sectors of the Cannabinoid and Medical Cannabis spaces to share the latest research and case studies. This will also be an opportunity to listen in on the Doctors personal journey into the Cannabinoid/Medical Cannabis Industries. “We’re known for the quality of our education,” says, Graciela Moreno, COO of MACE Media Group. “So with every expo, we like to experiment with new ways that we can offer the highest quality of education to our attendees,” says Moreno. Similar to Doc Talks, The CEO Talks will offer the opportunity for CEOs in the Cannabinoid space to share the personal story of their company and how it came to stand today. You’ll get the opportunity to listen in on the ups and downs of the industries from a first-hand perspective. As well as gain tips, tricks, and learn niches to better your own business.

Concurring the D8 Expo/CBD Expo panel discussions on October 7th will be The Psychedelic Medicine Conference. The Conference will be held from October 7th – 8th, bringing educational panel discussions on psychedelics’ biological, medicinal, and ethical aspects. With panel topics such as Psychedelics for Veterans: A New Hope for PTSD and Mental Health, Psychedelic and Your Body: What’s Happening Inside?, and Psychedelic Medicine: Safety & Ethical Concerns. On October 8th, a hands-on workshop will be held on how to grow mushrooms and the extraction process of mushrooms.

To purchase tickets for the Delta 8 Expo in Partnership with the CBD Expo Tour and Psychedelic Medicine Conference click Here

Network Partners

Follow Us on Social Media

Facebook

Twitter

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.